SSA
ZOM

Schonfeld Strategic Advisors’s Zomedica Corp. ZOM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-399,217
Closed -$209K – 2842
2021
Q3 		$209K Sell
399,217
-199,035
-33% -$117K ﹤0.01% 1744
2021
Q2 		$498K Buy
+598,252
New +$557K 0.01% 1197

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Schonfeld Strategic Advisors's ZOM Position: Q4 2021 in Review

Schonfeld Strategic Advisors sold out of Zomedica Corp. (ZOM) in Q4 2021, closing a stake of 399,217 shares — an estimated $209K sold.

Schonfeld Strategic Advisors first reported a position in ZOM in Q2 2021 and held it in 2 quarters. The position peaked at $498K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q4 2021.

  • Schonfeld Strategic Advisors reported no remaining Zomedica Corp. position as of Q4 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 399,217 Zomedica Corp. shares in Q4 2021, an estimated $209K.
  • Schonfeld Strategic Advisors first reported a position in Zomedica Corp. in Q2 2021 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Zomedica Corp. position peaked at $498K in Q2 2021.
  • 107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.